Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1993-4-20
pubmed:abstractText
Abelson murine leukemia virus (A-MuLV), a retrovirus that expresses the v-abl oncogene, characteristically induces pre-B-cell lymphomas following in vivo infection of BALB/c mice or in vitro infection of suspensions of fetal liver or bone marrow cells. ABL-MYC, a retrovirus that expresses both v-abl and c-myc, induces solely plasmacytomas in BALB/c mice. To investigate how the addition of overexpression of c-myc to that of v-abl accomplishes this dramatic change in the phenotype of the cells transformed by these closely related retroviruses, we utilized helper-free A-MuLV (psi 2) and ABL-MYC (psi 2) in vitro to infect suspensions of cells from different lymphoid tissues and purified immature and purified mature B cells. As expected, A-MuLV(psi 2) induced only pre-B-cell lymphomas in vivo and in vitro when immature B cells were present. ABL-MYC(psi 2), on the other hand, produced only plasmacytomas, even when purified immature B lymphocytes were infected in vitro. Although the A-MuLV(psi 2)-induced pre-B-cell lymphomas express easily detectable levels of c-myc mRNA, maturation into more-mature forms of B lymphocytes is blocked. The constitutively overexpressed c-myc in the ABL-MYC retrovirus abrogates this block, permits maturation of infected immature B cells, and yields transformed plasma cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1497324, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1525828, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1565479, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-163975, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1689065, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1710514, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-178822, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1827140, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1924333, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1970800, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-1986238, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2073789, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2153918, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2155783, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2539505, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2555703, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2848920, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2856928, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2908499, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-2987824, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-3088206, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-3311314, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-4355680, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6202819, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6257398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6278424, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6285962, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6302668, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6304522, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6327049, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6366066, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6678608, http://linkedlifedata.com/resource/pubmed/commentcorrection/8455630-6804938
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2578-85
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
pubmed:affiliation
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
pubmed:publicationType
Journal Article